skip to main content
WCU
Return
866-508-2684

Faculty Publications

About

Busuyi Olotu, PhD, MSPharm, BPharm

Publications

Rasu R, Olotu BS, Hansen ML, Raghavan D, Phadnis M, et al. Contemporary profile of chronic dialysis patients receiving oral P2Y12 inhibitors: A single center experience. Jour Ren Med. 2017; Vol.1 No.3: 14.

Sharma NK, Olotu B, Mathew A, Waitman LR, Rasu R. Lumbar spine surgeries and medication usage during hospital stay: one-center perspective. Hospital Pharmacy. 2017;52(11):774-780.

Olotu BS, Shepherd MD, Novak S, Lawson KA, Wilson JP, Richards KM, Rasu RS. Use of statins and the risk of incident diabetes: A retrospective cohort study. American Journal of Cardiovascular Drugs. 2016;16(5):377-390.

Ford KC, Olotu BS, Thach AV, Roberts RM, Davis PJFactors contributing to perceived academic stress among doctor of pharmacy students. College Student Journal. 2014; 48(2):189-198.

Olotu BS, Brown CM, Lawson KA, Barner JC. Complementary and alternative medicine (CAM) utilization in Texas hospices: prevalence and importance. American Journal of Hospice and Palliative Medicine. 2014;31(3):254-259.

Olotu BS, Brown CM, Barner JC, Lawson KA. Factors associated with hospices’ provision of CAM. American Journal of Hospice and Palliative Medicine. 2014;31(4):385-391.

Presentations

Hansen M, Olotu B, Jain N, Rasu R. “Discontinuation rates of oral P2Y12 inhibitors in end-stage renal disease patients on chronic dialysis,” at the American Society of Health-System Pharmacy Midyear Meeting, Las Vegas, NV, December 4-8, 2016.

Mitra S, El Atrouni W, Olotu B, Rasu R, Waitman. “Diabetes, Mortality, and the Burden of Comorbidities in People Living with HIV (PLHIV), and the Effect of Exposure to Protease Inhibitors: A Single-Center Study in the Midwestern United States,” at the Infectious Disease Week, New Orleans, LA, October 26-30, 2016.

Olotu BS, Shepherd MD, Novak S, Lawson KA, Wilson JP, Richards KM, Rasu RS. “Use of statins and the risk of incident diabetes: A retrospective cohort study,” at the International Society for Pharmacoeconomics and Outcomes Research 21st Annual Meeting, Washington, DC, May 24, 2016.

Olotu BS, Shepherd MD, Lawson KA, Richards KM, Wilson JP, Novak S, Rasu RS. ‘’Risk of diabetes among intensive and moderate dose statin users with potential modifying effects of treatment duration,’’ at the 2016 Resident, Postdoc, & Fellow Research Forum Presentation, University of Kansas Medical Center, Kansas City, KS, May 5, 2016.

Olotu BS, Shepherd MD, Novak S, Lawson KA, Wilson JP, Richards KM, Rasu RS. “Use of statins and the risk of incident diabetes: A retrospective cohort study,” at the Academy of Managed Care & Specialty Pharmacy Annual Meeting 2016, San Francisco, CA, April 21, 2016 (submitted as an en-core research report).

Olotu BS, Shepherd MD, Novak S, Lawson KA, Wilson JP, Richards KM, Rasu RS. “Use of statins and the risk of incident diabetes: A retrospective cohort study,” at the University of Kansas School of Pharmacy Graduate Honors, Lawrence, KS, January 13, 2016.

Singh RR, Olotu BS, Lawson KA. “Understanding the underutilization of colorectal cancer screening using the Medical Expenditure Panel Survey,” at the International Society of Pharmacoeconomics and Outcomes Research 19th Annual Meeting, Montreal, QC, Canada, May 31 – June 4, 2014.

Olotu BS, Ford KC, Roberts RM, Davis PJ. “Factors contributing to perceived academic stress among doctor of pharmacy students,” at the College of Pharmacy Ninth Annual Louis C. Littlefield Celebrating Pharmacy Research Excellence Day, Austin, TX, April 16, 2013.

Olotu BS, Ford KC, Roberts RM, Davis PJ. “Factors contributing to perceived academic stress among doctor of pharmacy students,” at the 2013 St. David's Center for Health Promotion & Disease Prevention Research in Underserved Populations (CHPR) Annual Conference, Austin, TX, March 27, 2013.

Olotu BS, Brown CM, Lawson KA, Barner JC. “Complementary and alternative medicine (CAM) utilization in Texas hospices,” at the International Society of Pharmacoeconomics and Outcomes Research 17th Annual Meeting, Washington, DC, June 6 – 12, 2012.

Olotu BS, Brown CM, Lawson KA, Barner JC. “Provision of complementary and alternative medicine (CAM) in Texas hospices: prevalence and challenges” at the Eighth Annual Louis C. Littlefield Celebrating Pharmacy Research Excellence Day, Austin, TX, April 17, 2012.

Olotu BS, Brown CM, Lawson KA, Barner JC. “Complementary and alternative medicine (CAM) utilization in Texas hospices: prevalence and challenges” at the American Pharmacists Association Annual Meeting and Exposition, New Orleans, LA, March 9 – 12, 2012.